Cuproptosis facilitates immune activation but promotes immune escape, and a machine learning-based cuproptosis-related signature is identified for predicting prognosis and immunotherapy response of gliomas.

Journal: CNS neuroscience & therapeutics
PMID:

Abstract

AIMS: Cell death, except for cuproptosis, in gliomas has been extensively studied, providing novel targets for immunotherapy by reshaping the tumor immune microenvironment through multiple mechanisms. This study aimed to explore the effect of cuproptosis on the immune microenvironment and its predictive power in prognosis and immunotherapy response.

Authors

  • Shi Feng
    Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, China.
  • Yonggang Zhang
    Department of Radiology, The First People's Hospital of Lianyungang, Lianyungang Clinical College of Nanjing Medical University, Lianyungang, China.
  • Hua Zhu
    School of Kinesiology, Shanghai University of Sport Shanghai, China.
  • Zhihong Jian
    Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
  • Zhi Zeng
    Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, China.
  • Yingze Ye
    Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
  • Yina Li
    Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, China.
  • Daniel Smerin
    Department of Neurosurgery, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
  • Xu Zhang
    China CDC Key Laboratory of Environment and Population Health, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 100021, China.
  • Ning Zou
    Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Lijuan Gu
    Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, China.
  • Xiaoxing Xiong
    Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.